Condition: Macromastia · Post-operative Pain · Sponsor: Connecticut Children's Medical Center
The main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intraoperatively receives 30cc of subpectoral bupivacaine injections or into the control group that intraoperatively receives 30cc of injectable saline subpectorally. All participants will keep a pain log and pain medication log at home for the first week following surgery. Researchers will compare to see if patients who receive subpectoral bupivacaine have lower pain scores in the PACU, and lower use of narcotics post-operatively when compared to the control group who receive injectable saline.
This description comes directly from the study's public registry record.
Lauren C Schmidtberg, PA-C · 860-545-9360 · lschmidtberg@connecticutchildrens.org
Christopher Hughes, MD, MPH · 860-545-9360 · chughes02@connecticutchildrens.org
Always discuss trial participation with your own doctor first.
| Connecticut Children's | Farmington, Connecticut, United States | Recruiting |
| Connecticut Children's | Hartford, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05898087